Impact of a factor Xa inhibitor (apixaban) on SIV pathogenesis and response to antiretroviral therapy.

Because the differences between groups were minimal and did not reach statistical significance, we concluded that apixaban had no effect on the recovery of circulating CD4 + T cells and their subsets.

also in 111,027 other papers